BioAdaptives Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $275.7K
- Price
- $0.0014
- % Change (Daily % change from the live per-ticker quote feed.)
- -22.22%
- Volume
- 38.9M
About
BioAdaptives, Inc. is a research and development company that develops and markets nutraceutical and dietary supplement products for humans and animals. Its products are derived from natural plant, fungi, and algal-based sources and include supplements for cognitive enhancement, weight management, and regenerative wellness.
Quick stats
Shares outstanding196.9M
Computed float196.7M
Float / shares99.9%
Key info
SectorHealthcare
IndustryMedical - Pharmaceuticals
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001575142
AI Summary
AI-generated1/16
minorbullishoperations update
BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video
BioAdaptives highlighted an Instagram video from paid brand ambassador Michael Bisping describing MyndMed as part of his pre-broadcast routine ahead of the UFC 331 pre-show on September 19.
Bisping, a UFC Hall of Famer and former middleweight champion, has been a paid ambassador since August 31, 2026, promoting the MyndSystem cognitive platform and Xcellara.
The release is purely promotional with no financial figures or business milestones; investors should note the paid endorsement nature and lack of revenue disclosure.
Red flags
- endorsement is from a paid brand ambassador, not organic use
- micro-cap OTC promotional release with no financial metrics disclosed
- product claims not evaluated by the FDA